Table 1. Demographic and disease characteristics by study.

	Focus Group (N=5)	Usability Testing Group (N=6)
Child Age (years; M(SD))	14.3 (1.29)	15.9 (1.29)
Time since diagnosis (years; M(SD))	3.6 (2.5)	2.6 (2.5)
Sex:
Male	40%	83%
Female	60%	17%
Child race
White: Non-Hispanic	100%	66.6%
White: Hispanic	0%	16.7%
African American	0%	16.7%
Family Duncan Score* (M(SD))	69.3 (14.0)	67.9 (15.1)
Participating Caregiver
Mother	83%	83%
Father	17%	17%
Caregiver Marital Status
Married	100%	83%
Divorced	0%	17%
Seizure Type and Etiology
Idiopathic Generalized	40%	16.7%
Idiopathic Localization-related	20%	33.3%
Idiopathic Unclassified	20%	33.3%
Symptomatic Localization-related	20%	16.7%
Seizures present in the past year	60%	33.3%
Antiepileptic Drug Prescribed
Carbamazepine	20%	16.7%
Levetiracetam	40%	66.7%
Oxcarbazepine	20%	16.7%
Valproate	20%	0%
% with clinically elevated BRIEF Scores (Parent/Adolescent)
Inhibition	40%/20%	0%/33%
Shift	20%/40%	17%/17%
Emotional Control	20%/40%	17%/17%
Initiation/Task Completion	40%/40%	0%/17%
Working Memory	20%/40%	0%/17%
Planning/Organization	20%/40%	0%/17%
Planning Organization of Materials	40%/20%	0%/17%
Monitor	20%/20%	0%/0%

^*Family Duncan score reflects the following types of occupations: 69.3-social worker, public administration; 67.9-financial officers, technician